Law & Regulation

Published by
Special to CorpWatch
|
By |
Six executives of Swiss pharmaceutical giant Novartis have been indicted in a South Korean bribery scandal. The indictments follow similar charges in China, Turkey and the U.S. and allegations of falsifying drug trial data in Japan. Korean prosecutors have recommended that Novartis sales be suspended for six months. Read More
Published by
Special to CorpWatch
|
By |
Gilead Sciences Inc., a California based pharmaceutical company, has avoided paying $10 billion in taxes by moving its patents to Ireland. This is despite the fact that one of its most profitable drugs was developed with U.S. taxpayer money, according to a new report from Americans for Tax Fairness. Read More
Published by
Special to CorpWatch
|
By |
Uruguay has defeated Philip Morris, the global tobacco giant, in a major international lawsuit over the country's tough anti-smoking regulations. The Swiss-based company sued Uruguay at the World Bank's International Center for Settlement of Investment Dispute under the terms of a 1991 bilateral investment treaty between Uruguay and Switzerland. Read More
Published by
Special to CorpWatch
|
By |
The U.S. government is investigating Citadel, a Chicago-based hedge firm and market maker that manages some $25 billion in client money, for allegedly giving smaller investors a bad deal. The Department of Justice wants to know if the firm is taking advantage of the complexity of high-speed trading. Read More
Published by
Special to CorpWatch
|
By |
The South African government has intervened to support the Indian-born Gupta brothers, owners of a sprawling conglomerate with interests from mining to media, following a scandal that suggested that the brothers had accumulated so much power that they could dictate cabinet-level decisions in the country. Read More
* indicates required